The Senior Director, Clinical Science, Oncology Early Development provides strategic Clinical Science leadership for novel assets from candidate transition through first-in-human development and clinical proof-of-concept. Reporting to the Executive Director, the role contributes to early development and scientific platform strategy through expertise in early-phase oncology, translational medicine, biomarker strategy, and first-in-human trial design. The position shapes development plans, strengthens scientific rigor, and enables objective, data-driven decision-making across the early oncology portfolio. The Senior Director integrates clinical, pharmacokinetic, pharmacodynamic, biomarker, safety, and external scientific evidence to inform indication strategy, dose escalation and optimization, cohort expansion, and proof-of-concept assessments. The role works closely with Section Heads, Asset Leads, Early Program Development Team Leads, study teams, and cross-functional leaders to guide study design, data interpretation, issue resolution, and program decisions. The position helps shape Clinical Science practices across the portfolio by advancing consistent standards, aligning scientific approaches, and integrating insights across assets. It may directly manage multiple Clinical Scientists and provides leadership, coaching, and direction in a matrix environment. The role collaborates with Clinical Operations, Regulatory Affairs, Biostatistics and Data Management, Drug Safety and Pharmacovigilance, Translational Medicine, Medical Affairs, and other partner functions, and contributes to governance discussions and senior leadership reviews. The role is hybrid, based primarily in Rahway, New Jersey, and requires 10% travel.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior